Head Topics

Common gout drug does not help hospitalised Covid-19 adults — UK study

  • 📰 TimesLIVE
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 59%

South Africa Headlines News

A commonly used gout drug did not have any effect on patients hospitalised with Covid-19, a large UK study found, prompting scientists to halt enrolments in a blow to finding uses for existing treatments in taming the pandemic.

An independent panel suggested pausing recruitment of volunteers in the colchicine arm of UK's RECOVERY trial, based on a preliminary analysis, scientists involved in the study said on Friday, adding that the panel did not think more volunteers could provide further data.

RECOVERY, backed by the UK government, is the world's largest trial of treatments for hospitalised Covid-19 adults and has found two treatments that could help survival chances in patients admitted with infection of the new coronavirus.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 28. in ZA

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.